Skip to content

Steris PLC

US · STE #909 by market cap Listed 1970
255.76 +1.00 +0.39%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
101.46% -0.10pp
Institutions
1,029 -3
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund86.97%
Hedge Fund6.76%
Public Company2.69%
Government Pension Fund1.50%
Private Company1.48%
Sovereign Wealth Fund1.27%
Individual/Insider0.33%
Insurance Company0.29%
Family Office/Trust0.26%

Top holders as of 2026-09-30

BlackRock 10.12% · 9.83M sh
Vanguard Capital Management, LLC 7.14% · 6.93M sh
State Street Global Advisors 5.34% · 5.18M sh
Vanguard Portfolio Management, LLC 5.10% · 4.95M sh
MFS Investment Management 3.93% · 3.81M sh
Wellington Management Group 3.53% · 3.43M sh
Orbis Investment Management Limited 3.16% · 3.07M sh
Geode Capital Management, LLC 2.73% · 2.65M sh
Morgan Stanley Investment Management Inc. 2.29% · 2.22M sh
Mitsubishi UFJ Asset Management 2.24% · 2.18M sh
Generation Investment Management LLP 2.34% · 2.28M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 22 buys · 28 sells

NameRoleStake
Daniel Carestio Chief Executive Officer 0.07%
Michael Tokich Former Senior Vice President 0.05%
Richard Breeden Former Independent Director 0.04%
John Zangerle Senior Vice President 0.04%
Jacqueline Kosecoff Former Independent Director 0.03%
Mohsen Sohi Independent Chairperson 0.03%
Cary Majors Senior VP & President of Healthcare 0.02%
Mary Fraser SVP & Chief Human Resources Officer 0.01%
Karen Burton Senior VP, CFO & Chief Accounting Officer 0.01%
Julia Madsen Senior VP & GM of Life Sciences 0.01%
Kenneth Kohler Senior VP & GM of AST 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-12 Julia Madsen Senior VP & GM of Life Sciences Intent to Sell (Form 144) -2,046 $260.00
2026-11-10 Karen Burton Senior VP, CFO & Chief Accounting Officer Derivative Exercise and Sale -5,880 $147.05–255.62
2026-11-09 Mohsen Sohi Independent Chairperson Derivative Exercise and Sale -4,893 $114.74–253.90
2026-09-30 Karen Burton Senior VP, CFO & Chief Accounting Officer Sale to Issuer -228 --
2026-08-17 Richard Breeden Former Independent Director Intent to Sell (Form 144) -4,110 $231.90
2026-08-11 Mohsen Sohi Independent Chairperson Derivative Exercise and Sale -4,058 $86.23–235.78
2026-08-09 Mohsen Sohi Independent Chairperson Other Derivative Acquisition +1,099 $238.91
2026-08-09 Mohsen Sohi Independent Chairperson Other Derivative Acquisition +1,229 --
2026-08-09 Cynthia Feldmann Independent Director Other Derivative Acquisition +512 --
2026-08-09 Cynthia Feldmann Independent Director Other Derivative Acquisition +1,506 $238.91
2026-08-09 Paul Martin Independent Director Other Derivative Acquisition +512 --
2026-08-09 Paul Martin Independent Director Other Derivative Acquisition +1,506 $238.91
2026-08-09 Nirav Shah Independent Director Other Derivative Acquisition +512 --
2026-08-09 Nirav Shah Independent Director Other Derivative Acquisition +1,506 $238.91
2026-08-09 Louis Shapiro Independent Director Other Derivative Acquisition +1,025 --
2026-08-09 Christopher Holland Independent Director Other Derivative Acquisition +1,025 --
2026-08-09 Pierre Boulud Independent Director Other Derivative Acquisition +1,025 --
2026-08-09 Esther Alegria Independent Director Other Derivative Acquisition +512 --
2026-08-09 Esther Alegria Independent Director Other Derivative Acquisition +1,506 $238.91
2026-06-30 Mohsen Sohi Independent Chairperson Derivative Exercise and Sale -1,837 $71.40–212.30

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:01:07 · For reference only, not investment advice and not tailored to your situation.

Steris PLC discussion 0 comments

Add a comment